Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis: reply
Rheumatology (Oxford)
.
2020 Jul 1;59(7):1783-1784.
doi: 10.1093/rheumatology/keaa083.
Authors
Tatiana Nevskaya
1
,
Boyang Zheng
2
,
Carl Baxter
3
,
Dena Ramey
4
,
Janet E Pope
1
,
Murray Baron
2
Affiliations
1
St Joseph Health Care, London, ON.
2
Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada.
3
MSD Ltd, Hoddesdon, UK.
4
Merck & Co., Inc., Kenilworth, NJ, USA.
PMID:
32160293
DOI:
10.1093/rheumatology/keaa083
No abstract available
Publication types
Comment
MeSH terms
Humans
Scleroderma, Diffuse*
Scleroderma, Systemic*
Skin